About Earum Pharmaceuticals
Earum Pharmaceuticals is a publicly listed company based in Ahmedabad (India) founded in 2012. Pharmaceutical formulation products are manufactured by Earum Pharmaceuticals in India. Its Indian entity Murae Organisor Limited reported revenue of ₹4.06 Cr. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.
Company details
Earum Pharmaceuticals was established in 2012 in Ahmedabad, India, within the pharmaceutical sector. Formulation products are produced as the primary operations. The company focuses on manufacturing activities for pharmaceutical needs. Leadership is held by Managing Director Bhumishth Patel. The domain earumpharma.com is maintained for online presence. Geographic operations are centered in India, supporting local and potential broader markets.
- Headquarters Ahmedabad, India
- Stage Public
- SectorsHealthcare
- Website earumpharma.com
- Social LinkedIn X Facebook Instagram
- Legal Name Murae Organisor Limited
- Annual Revenue₹4.06 Cr
FY 2024 · -75% YoY
- Net Profit₹5.3 Lakh
FY 2024 · 1% margin
- EBITDA₹39.5 Lakh
FY 2024 · 10% margin
Associated legal entities of Earum Pharmaceuticals
Earum Pharmaceuticals operates through Murae Organisor Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Murae Organisor Limited Listed CIN L24230GJ2012PLC071299 | Active | 26 Jul 2012 | Ahmedabad, Gujarat | ₹4.1 Cr | 15 | 6 | View details |
Board of directors of Murae Organisor Limited (Earum Pharmaceuticals)
Murae Organisor Limited is the primary company behind Earum Pharmaceuticals. The board of Murae Organisor Limited currently have 6 directors; the longest-serving is Nitinkumar Ashokkumar Tomar, appointed in 2024. 27 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nitinkumar Ashokkumar Tomar DIN 10820263 | Director | 09 Nov 2024 | 1 yr 11 mo | Murae Organisor Limited |
| Krunalbhai Desai DIN 10874142 | Director | 20 Dec 2024 | 1 yr 10 mo | Murae Organisor Limited |
| Ankit Patel DIN 11027945 | Additional Director | 29 Mar 2025 | 1 yr 7 mo | Murae Organisor Limited |
| Mayur Sureshkumar Vyas DIN 11027972 | Additional Director | 29 Mar 2025 | 1 yr 7 mo | Murae Organisor Limited |
| Vaishaliben Patel DIN 11027965 | Additional Director | 29 Mar 2025 | 1 yr 7 mo | Murae Organisor Limited |
| Chinmay Shrikant Pradhan DIN 10753724 | Managing Director | 29 Mar 2025 | 1 yr 7 mo | Murae Organisor Limited |
People of Earum Pharmaceuticals
1 people are tracked at Earum Pharmaceuticals (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Managing Director | Leadership |
Complete people profiles for Earum Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Earum Pharmaceuticals
Earum Pharmaceuticals is a publicly listed company on the BSE with ticker symbol MURAE in India, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date30 Jun 2020
- Listed onBSE: 542724
- Listed entityMurae Organisor Limited
- Exchange sectorDistribution services
- ISININE060601031
- Share price₹0.19 · 2026-05-11
- Market capitalisation₹38.9 Cr
- Price to earnings3.3
- Volume (last session)7,584,257
- Analyst consensusNo rating
Financials of Earum Pharmaceuticals
Figures of Murae Organisor Limited, the primary company behind Earum Pharmaceuticals, for FY 2024. Revenue was ₹4.06 Cr (-75% year on year). Net profit was ₹5.3 Lakh (1% margin). EBITDA was ₹39.5 Lakh (10% margin). Revenue has grown at a compounded annual rate of -57% over three years and -40% over five years.
- ₹4.06 CrRevenue · FY 2024 · -75% YoY
- ₹5.3 LakhNet profit · 1% margin
- ₹39.5 LakhEBITDA · 10% margin
- ₹186 CrPaid-up capital
- 15Employees (provident fund records)
- -57%Revenue CAGR, 3 years
- -40%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2024 | ₹855 Cr | ₹7.5 Cr | ₹10.0 Cr |
| 2023 | ₹3.2 Cr | ₹0.1 Cr | -₹0.5 Cr |
| 2022 | ₹14.9 Cr | ₹2.0 Cr | ₹1.8 Cr |
| 2021 | ₹21.0 Cr | ₹2.2 Cr | -₹4.4 Cr |
| 2020 | ₹41.1 Cr | ₹0.1 Cr | -₹7.7 Cr |
Balance sheet, profit and loss, cash flow and ratios of Murae Organisor Limited are on its company page.
Detailed financial statements for Earum Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Earum Pharmaceuticals
Earum Pharmaceuticals has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | Company offering a suite of R&D and manufacturing services for small molecules and generics | |||
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. |
Detailed similar companies of Earum Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Earum Pharmaceuticals (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Earum Pharmaceuticals
Complete news archive for Earum Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Earum Pharmaceuticals
Earum Pharmaceuticals was founded in 2012.
Earum Pharmaceuticals is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
The primary company behind Earum Pharmaceuticals, Murae Organisor Limited, reported revenue of ₹4.06 Cr for FY 2024, down 75% year on year.
Earum Pharmaceuticals was established in 2012 in Ahmedabad, India, within the pharmaceutical sector. Formulation products are produced as the primary operations. The company focuses on manufacturing activities for pharmaceutical needs. Leadership is held by Managing Director Bhumishth Patel. The domain earumpharma.com is maintained for online presence. Geographic operations are centered in India, supporting local and potential broader markets.
Earum Pharmaceuticals's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Yes, Earum Pharmaceuticals is publicly traded on BSE under the ticker symbol MURAE.
Earum Pharmaceuticals operates through Murae Organisor Limited.
The legal entities of Earum Pharmaceuticals currently have 6 directors, including Ankit Patel, Mayur Sureshkumar Vyas, Vaishaliben Patel and others.